Kerala government orders KMSCL to fast-track medicine purchases amid state-wide shortages
The Kerala government has directed the Kerala Medical Services Corporation Ltd. (KMSCL) to convene an emergency board meeting and immediately complete processing of pending medicine purchase orders, stepping in to address mounting shortages across the public health system.
Urgent mandate and inter-State sourcing
At a review meeting chaired by Health Minister K. Muraleedharan on Tuesday, KMSCL was authorised to explore procurement from other States if required. The agency was specifically asked to engage with the State medical corporations of Tamil Nadu and Rajasthan to secure supplies and bridge gaps in the near term, should local procurement remain constrained.
The instruction follows reports of shortfalls of several essential drugs—ranging from basic medicines and antibiotics to rabies vaccine—affecting facilities from peripheral primary care centres to tertiary hospitals. The shortages have been particularly concerning given the ongoing epidemic season, during which the State continues to log high numbers of infectious disease cases daily.
Stock position and supply chain bottlenecks
District medical officers told the meeting that while many hospitals still had medicines in hand, reserves were running low at KMSCL’s procurement and storage depots, raising the risk of future supply interruptions if replenishments do not arrive quickly.
Government hospitals have reported tightening supplies for several weeks. While the administration initially declined to acknowledge the scale of the problem, the Health Minister has since conceded that some medicines are in short supply and said efforts are under way to accelerate procurement.
Procurement delays and re-tendering
The immediate crunch has been linked to delays in KMSCL’s annual procurement cycle and subsequent re-tendering. KMSCL is the central agency tasked with supplying medicines and medical consumables to around 8,000 government health-care institutions statewide. In the latest procurement exercise, 180 items reportedly received no bids, while suppliers quoted higher prices for another 171 items. The combination necessitated re-tendering for a significant number of products and pushed back the placement of fresh orders.
These procurement challenges have coincided with increased seasonal demand, compounding pressures on the public health network and prompting the State to move on multiple fronts to avert stockouts.
Short-term measures and funding constraints
As an immediate stopgap, the government has authorised hospitals to make local purchases using hospital development society funds. However, administrators cautioned that many institutions lack adequate liquidity because of large overdue payments owed to them by the government—arrears that date back to the previous Left Democratic Front administration and have worsened over the years.
Given these constraints, the administration’s push for KMSCL to close purchase orders swiftly and, if necessary, diversify sourcing through other States is seen as critical to stabilising supplies in the short term.
Minister’s timeline and next procurement cycle
Mr. Muraleedharan said consignments for which purchase orders have already been placed are expected to reach hospitals shortly and that all possible steps are being taken to expedite deliveries. He set October 15 as the deadline to resolve the present shortage, signalling a compressed timeline for remedial action.
Looking ahead, the Minister asked KMSCL to begin the procurement process for the next financial year in October itself and complete it by the end of December. Under that schedule, supplies from the new cycle are expected to begin arriving from February 2027. The move is intended to reduce last-minute bottlenecks and provide greater predictability for the health system.
Epidemic control and field operations
Alongside supply-chain fixes, the Health Minister directed district health authorities to intensify field-level interventions to curb infectious diseases. He instructed officials to ensure the availability of essential drugs at peripheral facilities and to step up surveillance and public outreach. Health inspectors and other field workers have been asked to identify disease hotspots and prioritise home visits to raise awareness and reinforce preventive measures in communities.
Participants and oversight
Senior health officials, district medical officers and representatives from KMSCL attended the review meeting. The directives issued encompass both administrative measures—such as emergency board sessions and accelerated tender processing—and on-the-ground public health activities tailored to the current epidemic context.
Why it matters
The State’s intervention underscores the dual challenge of managing a seasonal surge in infectious diseases while navigating procurement delays and fiscal constraints within the public health system. Ensuring steady medicine supply to approximately 8,000 government facilities is pivotal to maintaining essential services, especially for vulnerable populations who depend on public hospitals and primary care centres.
With a firm mid-October deadline, instructions to explore inter-State sourcing, and an early start to the next procurement cycle, the government has outlined a time-bound plan to restore normalcy in medicine availability. Its effectiveness will hinge on KMSCL’s ability to rapidly close tenders, secure supplies, and coordinate distribution—while district-level teams reinforce epidemic control efforts to reduce pressure on the health network in the weeks ahead.
